Counseling of Pregnant Women During Corona

• Sponsor: Aljazeera Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT04317365
• Collaborator: (none)
• Enrollment: 200
• Location: 1
• Arms: 2
• Actual Duration (Months): 2
• Patients Per Site Per Month: 98.2

Study Details

Study Description

Brief Summary

Corona virus is known as covid 19 And is transmitted through droplet infection

Condition or Disease	Intervention/Treatment	Phase
Respiratory Tract Infections	Other: Women receiving extra remembering by healthcare	N/A

Detailed Description

Symptoms of Corona include cough Fever and dyspnea

Study Design

• Study Type: Interventional
• Actual Enrollment: 200 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Supportive Care
• Official Title: Effect of Counseling Between Pregnant Women During Corona Infection
• Actual Study Start Date: Mar 24, 2020
• Actual Primary Completion Date: Apr 26, 2020
• Actual Study Completion Date: May 25, 2020

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: patients receiving remembering	Other: Women receiving extra remembering by healthcare; Women receiving extra remembering by healthcare in covid infection
No Intervention: patients not receiving extra remembering

Outcome Measures

Primary Outcome Measures

1. The number of pregnant women who know the exact symptoms of the disease [Within one month]

   The number of pregnant women who have awareness about the disease

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 43 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• pregnant women

Exclusion Criteria:

• non pregnant women

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Algazeerah and Kasralainy hospital	Giza		Egypt

Sponsors and Collaborators

• Aljazeera Hospital

Investigators

• Study Chair: Mahmoud Alalfy, Algezeera hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Aljazeera Hospital
• ClinicalTrials.gov Identifier: NCT04317365
• Other Study ID Numbers: Respiratory infection
• First Posted: Mar 23, 2020
• Last Update Posted: Jun 4, 2020
• Last Verified: Jun 1, 2020

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Infections; Respiratory Tract Infections

Study Results

No Results Posted as of Jun 4, 2020